Breast Conservation Rates and Outcomes in Postmenopausal Women With Estrogen Receptor-positive Breast Cancer Treated With Neoadjuvant Hormonal Therapy or Chemotherapy

Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer

Frontiers in Oncology ◽

10.3389/fonc.2013.00317 ◽

2013 ◽

Vol 3 ◽

Cited By ~ 2

Author(s):

David M. Marcus ◽

Jeffrey M. Switchenko ◽

Roshan Prabhu ◽

Ruth O’Regan ◽

Amelia Zelnak ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Neoadjuvant Chemotherapy ◽

Hormonal Therapy ◽

Neoadjuvant Hormonal Therapy ◽

Menopausal Women ◽

Post Menopausal ◽

HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women

Breast Cancer Research ◽

10.1186/s13058-018-1072-1 ◽

2018 ◽

Vol 20 (1) ◽

Cited By ~ 2

Author(s):

Anja Kathrin Wege ◽

Dominik Chittka ◽

Stefan Buchholz ◽

Monika Klinkhammer-Schalke ◽

Simone Diermeier-Daucher ◽

...

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Estrogen Receptor ◽

Postmenopausal Women ◽

Tamoxifen Treatment ◽

Her4 Expression ◽

Adjuvant tamoxifen for pre- and postmenopausal women with estrogen receptor positive, node positive breast cancer: A randomized study

Breast Cancer Research and Treatment ◽

10.1007/bf00690184 ◽

1995 ◽

Vol 36 (1) ◽

pp. 49-53 ◽

Cited By ~ 14

Author(s):

S. Gundersen ◽

E. Hannisdal ◽

J. A. S�reide ◽

A. Skarstein ◽

J. E. Varhaug

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Postmenopausal Women ◽

Randomized Study ◽

Positive Node ◽

Adjuvant Tamoxifen ◽

Node Positive ◽

Aromatase inhibitors versus tamoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: meta-analyses of randomized trials of monotherapy and switching strategies.

10.1158/0008-5472.sabcs-12 ◽

2009 ◽

Cited By ~ 17

Author(s):

JN Ingle ◽

M Dowsett ◽

J Cuzick ◽

C Davies

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Adjuvant Therapy ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Randomized Trials ◽

Meta Analyses ◽

Switching Strategies ◽

Abstract OT2-1-04: Alliance A011106: ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: A phase III study

10.1158/1538-7445.sabcs14-ot2-1-04 ◽

2015 ◽

Author(s):

Cynthia X Ma ◽

Vera Suman ◽

A Marilyn Leitch ◽

Souzan Sanati ◽

Katherine DeSchryver ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Postmenopausal Women ◽

Clinical Stage ◽

Neoadjuvant Treatment ◽

Stage Ii ◽

Phase Iii ◽

Phase Iii Study ◽

A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-009-0646-0 ◽

2009 ◽

Vol 119 (3) ◽

pp. 643-651 ◽

Cited By ~ 22

Author(s):

Fiona M. McCaig ◽

Lorna Renshaw ◽

Linda Williams ◽

Oliver Young ◽

Juliette Murray ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Bone Metabolism ◽

Postmenopausal Women ◽

Aromatase Inhibitors ◽

Abstract A107: Income disparities in the receipt and adherence to adjuvant hormonal therapy in a cohort of young estrogen receptor-positive breast cancer cases

10.1158/1055-9965.disp-11-a107 ◽

2011 ◽

Author(s):

Jean A. McDougall ◽

Christopher I. Li

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Hormonal Therapy ◽

Adjuvant Hormonal Therapy ◽

Income Disparities ◽

Genes associated with serum estrone, estrone conjugates, and androstenedione concentrations in postmenopausal women with estrogen receptor-positive breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.593 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 593-593 ◽

Cited By ~ 2

Author(s):

Tanda M. Dudenkov ◽

James N. Ingle ◽

Aman Buzdar ◽

Mark E. Robson ◽

Michiaki Kubo ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Postmenopausal Women ◽

The role of E2F1 as a prognostic and predictive parameter in estrogen receptor positive breast cancer patients undergoing anti hormonal therapy

Geburtshilfe und Frauenheilkunde ◽

10.1055/s-0029-1225212 ◽

2009 ◽

Vol 69 (05) ◽

Author(s):

E Kandolf ◽

EM Fuchs ◽

G Hudelist ◽

B Weidinger ◽

C Singer

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Patients ◽

Hormonal Therapy ◽

Breast Cancer Patients ◽

A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-15-2160 ◽

2016 ◽

Vol 22 (11) ◽

pp. 2650-2658 ◽

Cited By ~ 40

Author(s):

Cynthia X. Ma ◽

Cesar Sanchez ◽

Feng Gao ◽

Robert Crowder ◽

Michael Naughton ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Metastatic Breast Cancer ◽

Phase I ◽

Postmenopausal Women ◽

Hormonal Therapy ◽

Phase I Study ◽

Metastatic Breast ◽

Akt Inhibitor ◽

Estrogen Receptor Positive